Thursday, June 4, 2026

#ophthalmology

2 articles

Biotech Firms Secure Capital as Gene Therapy Trials Target 5 Million Global Patients with Dry AMD

Biotech Firms Secure Capital as Gene Therapy Trials Target 5 Million Global Patients with Dry AMD

Salvado•Mar 26, 2026

Biotech Funding Drought Puts $300M Ophthalmology Drug at Risk of Capital Collapse

Biotech Funding Drought Puts $300M Ophthalmology Drug at Risk of Capital Collapse

ViaNews Editorial Team•Mar 1, 2026